CD4 and influenza: A group of scientists also targeted influenza M2e to DCs by fusing M2e with anti-Clec9 (Park et al., 2017), while HA of influenza was infused with an artificial adjuvant vector cell targeting DCs to induce CD4+ T cells and CD4+ Tfh cells (Yamasaki et al., 2016).